These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment of chronic recurrent erysipelas with streptococcal vaccine]. Haustein UF; Biella U; Tausch I; Knöll H Hautarzt; 1989 Apr; 40(4):215-21. PubMed ID: 2659550 [TBL] [Abstract][Full Text] [Related]
3. [Problems of treatment and prevention of erysipelas recurrence with streptococcal vaccine]. Haustein UF; Hildebrand M Dtsch Gesundheitsw; 1971 Apr; 26(16):735-40. PubMed ID: 5576713 [No Abstract] [Full Text] [Related]
4. [The importance of local factors in recurrent erysipelas]. Stöberl C Z Hautkr; 1985 May; 60(9):712, 715-8, 721-3. PubMed ID: 4013460 [TBL] [Abstract][Full Text] [Related]
5. Problems of erysipelas. 3. Streptococcal vaccine treatment of relapsing erysipelas. Korossy S; Rajka O; Böszörményi J; Gózony M Acta Med Acad Sci Hung; 1968; 25(1):51-61. PubMed ID: 5678738 [No Abstract] [Full Text] [Related]
6. Erysipelas of the upper extremity following locoregional therapy for breast cancer. El Saghir NS; Otrock ZK; Bizri AR; Uwaydah MM; Oghlakian GO Breast; 2005 Oct; 14(5):347-51. PubMed ID: 15990307 [TBL] [Abstract][Full Text] [Related]
7. Our experience with mixed bacterial vaccine treatment in allergic skin disease. Csizér Z; Zsidai J; Korossy S; Lovas L; Vincze E Ann Immunol Hung; 1975; 18():17-28. PubMed ID: 1235948 [No Abstract] [Full Text] [Related]
8. [Experience with the treatment of allergic skin diseases with mixed bacterial vaccine]. Zoltan C; Jozsef Z; Sandor K; Laszlo L; Erzebet V Orv Hetil; 1975 Apr; 116(17):983-7. PubMed ID: 1143836 [No Abstract] [Full Text] [Related]
9. [Protection of an oral vaccine against experimental infection of mice and its role combined with the administration of penicillin]. Gismondo MR; Lo Bue AM; Chisari G; Stivala F G Batteriol Virol Immunol; 1990; 83(1-12):84-7. PubMed ID: 2133331 [TBL] [Abstract][Full Text] [Related]
10. [Current methods of treating patients with erysipelas]. Cherkasov VL Klin Med (Mosk); 1972 Mar; 50(3):132-6. PubMed ID: 5024817 [No Abstract] [Full Text] [Related]
11. [Considerations on the treatment of recurrent erysipelas and on the prevention of elephantiasis]. RESL V; WIERER A Cesk Dermatol; 1961 May; 36():174-9. PubMed ID: 13740939 [No Abstract] [Full Text] [Related]
12. [Treatment of erysipelas]. SCHEMBRA FW Dtsch Med Wochenschr; 1955 Jul; 80(29-30):1093-4. PubMed ID: 13250963 [No Abstract] [Full Text] [Related]
13. [Therapy of recurring erysipelas]. Herrmann WP; Reinhold M Dtsch Med Wochenschr; 1982 Mar; 107(11):428-9. PubMed ID: 6800755 [No Abstract] [Full Text] [Related]
14. Delayed-type hypersensitivity to beta-hemolytic streptococci in patients with recurrent uveitis and its therapy by means of streptococcus vaccines. Hána I; Klenka L; Koleckárová M; Hejdová E Zentralbl Bakteriol Orig; 1970; 214(3):377-82. PubMed ID: 4994143 [No Abstract] [Full Text] [Related]
15. [Primary and secondary prevention for erysipelas]. Becq-Giraudon B Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 2):368-75. PubMed ID: 11319367 [TBL] [Abstract][Full Text] [Related]
16. [Erysipelas and lymphedema]. Herpertz U Fortschr Med; 1998 Apr; 116(12):36-40. PubMed ID: 9622973 [TBL] [Abstract][Full Text] [Related]
17. [Characteristics of the clinical course of erysipelas]. Suleĭmenova ZI; Turkpenbaeva GZh; Tsoĭ IG; Turkpenbaeva AZh Klin Med (Mosk); 1985 Jan; 63(1):125-8. PubMed ID: 3990177 [No Abstract] [Full Text] [Related]
18. Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study. Vignes S; Dupuy A J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):818-22. PubMed ID: 16898904 [TBL] [Abstract][Full Text] [Related]